Koenig Sheldon L. 4
4 · Esperion Therapeutics, Inc. · Filed Mar 17, 2025
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy
2025-03-14+753,000→ 753,000 totalExercise: $1.50Exp: 2035-03-14→ Common Stock (753,000 underlying) - Award
Common Stock
2025-03-14+840,000→ 1,585,009 total
Footnotes (2)
- [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2025.
- [F2]Includes 5,190 shares recently acquired in Esperion's Employee Stock Purchase Plan